Search Results - "Wu, Jennifer D"

Refine Results
  1. 1

    Targeting CD73 to augment cancer immunotherapy by Roh, Meejeon, Wainwright, Derek A, Wu, Jennifer D, Wan, Yong, Zhang, Bin

    Published in Current opinion in pharmacology (01-08-2020)
    “…•CD73 is a multifunctional ectoenzyme affecting both tumor cells and immune cells.•CD73 has been hijacked by TME to promote tumor growth and…”
    Get full text
    Journal Article
  2. 2

    Preoperative anxiety and implications on postoperative recovery: what can we do to change our history by Stamenkovic, Dusica M, Rancic, Nemanja K, Latas, Milan B, Neskovic, Vojislava, Rondovic, Goran M, Wu, Jennifer D, Cattano, Davide

    Published in Minerva anestesiologica (01-11-2018)
    “…Preoperative anxiety can influence the intensity of postoperative pain and anesthesia and analgesia requirement. In certain types of surgery, anxiety may even…”
    Get full text
    Journal Article
  3. 3

    Immunosuppressive IDO in Cancer: Mechanisms of Action, Animal Models, and Targeting Strategies by Zhai, Lijie, Bell, April, Ladomersky, Erik, Lauing, Kristen L, Bollu, Lakshmi, Sosman, Jeffrey A, Zhang, Bin, Wu, Jennifer D, Miller, Stephen D, Meeks, Joshua J, Lukas, Rimas V, Wyatt, Eugene, Doglio, Lynn, Schiltz, Gary E, McCusker, Robert H, Wainwright, Derek A

    Published in Frontiers in immunology (16-06-2020)
    “…Indoleamine 2, 3-dioxygenase 1 (IDO; IDO1; INDO) is a rate-limiting enzyme that metabolizes the essential amino acid, tryptophan, into downstream kynurenines…”
    Get full text
    Journal Article
  4. 4

    Past, Current, and Future of Immunotherapies for Prostate Cancer by Boettcher, Adeline N, Usman, Ahmed, Morgans, Alicia, VanderWeele, David J, Sosman, Jeffrey, Wu, Jennifer D

    Published in Frontiers in oncology (11-09-2019)
    “…Prostate cancer (PCa) is the most common cancer in men, and the second leading cause of cancer related death in men in Western countries. The standard therapy…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Proliferation and enrichment of CD133+ glioblastoma cancer stem cells on 3D chitosan-alginate scaffolds by Kievit, Forrest M, Florczyk, Stephen J, Leung, Matthew C, Wang, Kui, Wu, Jennifer D, Silber, John R, Ellenbogen, Richard G, Lee, Jerry S.H, Zhang, Miqin

    Published in Biomaterials (01-11-2014)
    “…Abstract Emerging evidence implicates cancer stem cells (CSCs) as primary determinants of the clinical behavior of human cancers, representing an ideal target…”
    Get full text
    Journal Article
  7. 7

    Perturbation of NK cell peripheral homeostasis accelerates prostate carcinoma metastasis by Liu, Gang, Lu, Shengjun, Wang, Xuanjun, Page, Stephanie T, Higano, Celestia S, Plymate, Stephen R, Greenberg, Norman M, Sun, Shaoli, Li, Zihai, Wu, Jennifer D

    Published in The Journal of clinical investigation (01-10-2013)
    “…The activating receptor NK cell group 2 member D (NKG2D) mediates antitumor immunity in experimental animal models. However, whether NKG2D ligands contribute…”
    Get full text
    Journal Article
  8. 8
  9. 9

    The expression profile and clinic significance of the SIX family in non-small cell lung cancer by Liu, Qian, Li, Anping, Tian, Yijun, Liu, Yu, Li, Tengfei, Zhang, Cuntai, Wu, Jennifer D, Han, Xinwei, Wu, Kongming

    Published in Journal of hematology and oncology (08-11-2016)
    “…The SIX family homeobox genes have been demonstrated to be involved in the tumor initiation and progression, but their clinicopathological features and…”
    Get full text
    Journal Article
  10. 10

    Cutting Edge: The Membrane Type Matrix Metalloproteinase MMP14 Mediates Constitutive Shedding of MHC Class I Chain-Related Molecule A Independent of A Disintegrin and Metalloproteinases by Liu, Gang, Atteridge, Catherine L, Wang, Xuanjun, Lundgren, Ashley D, Wu, Jennifer D

    Published in The Journal of immunology (1950) (01-04-2010)
    “…Abstract Engagement of tumor cell surface MHC class I chain-related molecule A (MICA) to NKG2D stimulates NK and T cell antitumor immunity. Shedding of MICA by…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Antibody targeting tumor-derived soluble NKG2D ligand sMIC reprograms NK cell homeostatic survival and function and enhances melanoma response to PDL1 blockade therapy by Basher, Fahmin, Dhar, Payal, Wang, Xin, Wainwright, Derek A, Zhang, Bin, Sosman, Jeffrey, Ji, Zhe, Wu, Jennifer D

    Published in Journal of hematology and oncology (09-06-2020)
    “…Melanoma patients who have detectable serum soluble NKG2D ligands either at the baseline or post-treatment of PD1/PDL1 blockade exhibit poor overall survival…”
    Get full text
    Journal Article
  13. 13

    NKG2D and its ligands in cancer by Dhar, Payal, Wu, Jennifer D

    Published in Current opinion in immunology (01-04-2018)
    “…•NKG2D pathway is significant for both innate and adoptive tumor immunity.•Soluble and membrane-bound NKG2D ligands confer opposite role in tumor…”
    Get full text
    Journal Article
  14. 14

    Interaction of IGF signaling and the androgen receptor in prostate cancer progression by Wu, Jennifer D., Haugk, Kathy, Woodke, Libby, Nelson, Peter, Coleman, Ilsa, Plymate, Stephen R.

    Published in Journal of cellular biochemistry (01-10-2006)
    “…The insulin‐like growth factor type I receptor (IGF‐IR) has been suggested to play an important role in prostate cancer progression and possibly in the…”
    Get full text
    Journal Article
  15. 15

    Antibody targeting tumor-derived soluble NKG2D ligand sMIC provides dual co-stimulation of CD8 T cells and enables sMIC + tumors respond to PD1/PD-L1 blockade therapy by Zhang, Jinyu, Larrocha, Pablo Saenz-Lopez, Zhang, Bin, Wainwright, Derek, Dhar, Payal, Wu, Jennifer D

    Published in Journal for immunotherapy of cancer (26-08-2019)
    “…Insufficient co-stimulation accounts for a great deal of the suboptimal activation of cytotoxic CD8 T cells (CTLs) and presumably unsatisfactory clinical…”
    Get full text
    Journal Article
  16. 16

    Prevalent expression of the immunostimulatory MHC class I chain-related molecule is counteracted by shedding in prostate cancer by Wu, Jennifer D, Higgins, Lily M, Steinle, Alexander, Cosman, David, Haugk, Kathy, Plymate, Stephen R

    Published in The Journal of clinical investigation (01-08-2004)
    “…The MHC class I chain-related molecules (MICs) have previously been shown to be induced on most epithelial tumor cells. Engagement of MIC by the activating…”
    Get full text
    Journal Article
  17. 17

    Direct N-Glycosylation Profiling of Urine and Prostatic Fluid Glycoproteins and Extracellular Vesicles by Blaschke, Calvin R K, Hartig, Jordan P, Grimsley, Grace, Liu, Liping, Semmes, O John, Wu, Jennifer D, Ippolito, Joseph E, Hughes-Halbert, Chanita, Nyalwidhe, Julius O, Drake, Richard R

    Published in Frontiers in chemistry (27-09-2021)
    “…Expressed prostatic secretions (EPS), also called post digital rectal exam urines, are proximal fluids of the prostate that are widely used for diagnostic and…”
    Get full text
    Journal Article
  18. 18

    3D Porous Chitosan-Alginate Scaffolds: A New Matrix for Studying Prostate Cancer Cell-Lymphocyte Interactions In Vitro by Florczyk, Stephen J., Liu, Gang, Kievit, Forrest M., Lewis, Allison M., Wu, Jennifer D., Zhang, Miqin

    Published in Advanced healthcare materials (01-09-2012)
    “…The treatment of castration‐resistant prostate cancer (CRPC) remains palliative. Immunotherapy offers a potentially effective therapy for CRPC; however, its…”
    Get full text
    Journal Article
  19. 19

    National Origin Identity and Descriptive Representativeness: Understanding Preferences for Asian Candidates and Representation by Wu, Jennifer D

    Published in Public opinion quarterly (23-12-2023)
    “…Abstract This paper examines how an Asian candidate’s national origin background affects their perceived ability to represent different constituents. Would…”
    Get full text
    Journal Article
  20. 20

    The Human Soluble NKG2D Ligand Differentially Impacts Tumorigenicity and Progression in Temporal and Model-Dependent Modes by Serritella, Anthony V, Saenz-Lopez Larrocha, Pablo, Dhar, Payal, Liu, Sizhe, Medd, Milan M, Jia, Shengxian, Cao, Qi, Wu, Jennifer D

    Published in Biomedicines (01-01-2024)
    “…NKG2D is an activating receptor expressed by all human NK cells and CD8 T cells. Harnessing the NKG2D/NKG2D ligand axis has emerged as a viable avenue for…”
    Get full text
    Journal Article